tiprankstipranks
Trending News
More News >
Tenet Healthcare Corp. (THC)
:THC
US Market

Tenet Healthcare (THC) Stock Forecast & Price Target

Compare
864 Followers
See the Price Targets and Ratings of:

THC Analyst Ratings

Strong Buy
17Ratings
Strong Buy
15 Buy
2 Hold
0 Sell
Based on 17 analysts giving stock ratings to
Tenet
Healthcare
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

THC Stock 12 Month Forecast

Average Price Target

$184.71
▲(8.72%Upside)
Based on 17 Wall Street analysts offering 12 month price targets for Tenet Healthcare in the last 3 months. The average price target is $184.71 with a high forecast of $230.00 and a low forecast of $137.00. The average price target represents a 8.72% change from the last price of $169.89.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"125":"$125","178":"$178","231":"$231","151.5":"$151.5","204.5":"$204.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":230,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$230.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":184.71,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$184.71</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":137,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$137.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[125,151.5,178,204.5,231],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,170.12,174.72615384615386,179.3323076923077,183.93846153846155,188.54461538461538,193.15076923076924,197.75692307692307,202.36307692307693,206.96923076923076,211.57538461538462,216.18153846153845,220.7876923076923,225.39384615384614,{"y":230,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,170.12,171.2423076923077,172.36461538461538,173.4869230769231,174.60923076923078,175.73153846153846,176.85384615384615,177.97615384615386,179.09846153846155,180.22076923076924,181.34307692307692,182.46538461538464,183.58769230769232,{"y":184.71,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,170.12,167.5723076923077,165.0246153846154,162.47692307692307,159.92923076923077,157.38153846153847,154.83384615384617,152.28615384615384,149.73846153846154,147.19076923076923,144.64307692307693,142.0953846153846,139.5476923076923,{"y":137,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":135.22,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.3,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":147.95,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":165.84,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":162.87,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":156.13,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":142.03,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":126.23,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":140.89,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":126.59,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.4,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.29,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":170.12,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$230.00Average Price Target$184.71Lowest Price Target$137.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on THC
TipRanks AITipRanks
Not Ranked
TipRanks
$195
Buy
14.78%
Upside
Reiterated
06/05/25
Tenet Healthcare's overall strong financial performance and bullish technical indicators significantly drive its stock score. The undervalued P/E ratio further enhances its attractiveness, though potential risks from healthcare policy uncertainties and a relatively high liability level slightly temper the outlook.
Leerink Partners Analyst forecast on THC
Whit MayoLeerink Partners
Leerink Partners
$170$209
Buy
23.02%
Upside
Reiterated
06/04/25
Leerink Partners Sticks to Its Buy Rating for Tenet Healthcare (THC)
Barclays
$171$215
Buy
26.55%
Upside
Reiterated
06/03/25
Tenet Healthcare price target raised to $215 from $171 at BarclaysTenet Healthcare price target raised to $215 from $171 at Barclays
Wells Fargo Analyst forecast on THC
Stephen BaxterWells Fargo
Wells Fargo
$150$195
Buy
14.78%
Upside
Upgraded
05/29/25
Positive Report for Tenet Healthcare (THC) from Wells Fargo
Cantor Fitzgerald Analyst forecast on THC
Sarah JamesCantor Fitzgerald
Cantor Fitzgerald
$177
Buy
4.19%
Upside
Reiterated
05/28/25
Cantor Fitzgerald Keeps Their Buy Rating on Tenet Healthcare (THC)
Mizuho Securities Analyst forecast on THC
Ann HynesMizuho Securities
Mizuho Securities
$170$184
Buy
8.31%
Upside
Reiterated
05/20/25
Tenet Healthcare (THC) PT Raised to $184 at MizuhoMizuho analyst Ann Hynes raised the price target on Tenet Healthcare (NYSE: THC) to $184.00 (from $170.00) while maintaining a Outperform rating.
Bank of America Securities Analyst forecast on THC
Joanna GajukBank of America Securities
Bank of America Securities
$165$180
Buy
5.95%
Upside
Reiterated
05/16/25
Tenet Healthcare (THC) PT Raised to $180 at BofA Securities following fireside chatBofA Securities analyst Joanna Gajuk raised the price target on Tenet Healthcare (NYSE: THC) to $180.00 (from $165.00) while maintaining a Buy rating.
J.P. Morgan Analyst forecast on THC
Benjamin RossiJ.P. Morgan
J.P. Morgan
$190
Buy
11.84%
Upside
Reiterated
05/14/25
Analysts Are Bullish on Top Healthcare Stocks: Codexis (CDXS), Neurocrine (NBIX)
Truist Financial Analyst forecast on THC
David S MacdonaldTruist Financial
Truist Financial
$175$190
Buy
11.84%
Upside
Reiterated
05/12/25
Tenet Healthcare price target raised to $190 from $175 at TruistTenet Healthcare price target raised to $190 from $175 at Truist
Goldman Sachs Analyst forecast on THC
Jamie PerseGoldman Sachs
Goldman Sachs
$134$154
Hold
-9.35%
Downside
Reiterated
05/05/25
Tenet Healthcare (THC) PT Raised to $154 at Goldman SachsGoldman Sachs analyst Jamie Perse raised the price target on Tenet Healthcare (NYSE: THC) to $154.00 (from $134.00) while maintaining a Neutral rating.
UBS
$217$230
Buy
35.38%
Upside
Reiterated
04/30/25
Tenet Healthcare price target raised to $230 from $217 at UBSTenet Healthcare price target raised to $230 from $217 at UBS
RBC Capital Analyst forecast on THC
Ben HendrixRBC Capital
RBC Capital
$183$189
Buy
11.25%
Upside
Reiterated
04/30/25
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (NASDAQ: ABVX), Atricure (NASDAQ: ATRC) and Tenet Healthcare (NYSE: THC)
KeyBanc
$185
Buy
8.89%
Upside
Reiterated
04/30/25
KeyBanc Remains a Buy on Tenet Healthcare (THC)
Guggenheim Analyst forecast on THC
Jason CassorlaGuggenheim
Guggenheim
$165$180
Buy
5.95%
Upside
Reiterated
04/29/25
Tenet Healthcare price target raised to $180 from $165 at GuggenheimTenet Healthcare price target raised to $180 from $165 at Guggenheim
TD Cowen
$175
Buy
3.01%
Upside
Reiterated
04/29/25
Tenet Healthcare's Strong Performance and Strategic Focus Justify Buy Rating
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on THC
TipRanks AITipRanks
Not Ranked
TipRanks
$195
Buy
14.78%
Upside
Reiterated
06/05/25
Tenet Healthcare's overall strong financial performance and bullish technical indicators significantly drive its stock score. The undervalued P/E ratio further enhances its attractiveness, though potential risks from healthcare policy uncertainties and a relatively high liability level slightly temper the outlook.
Leerink Partners Analyst forecast on THC
Whit MayoLeerink Partners
Leerink Partners
$170$209
Buy
23.02%
Upside
Reiterated
06/04/25
Leerink Partners Sticks to Its Buy Rating for Tenet Healthcare (THC)
Barclays
$171$215
Buy
26.55%
Upside
Reiterated
06/03/25
Tenet Healthcare price target raised to $215 from $171 at BarclaysTenet Healthcare price target raised to $215 from $171 at Barclays
Wells Fargo Analyst forecast on THC
Stephen BaxterWells Fargo
Wells Fargo
$150$195
Buy
14.78%
Upside
Upgraded
05/29/25
Positive Report for Tenet Healthcare (THC) from Wells Fargo
Cantor Fitzgerald Analyst forecast on THC
Sarah JamesCantor Fitzgerald
Cantor Fitzgerald
$177
Buy
4.19%
Upside
Reiterated
05/28/25
Cantor Fitzgerald Keeps Their Buy Rating on Tenet Healthcare (THC)
Mizuho Securities Analyst forecast on THC
Ann HynesMizuho Securities
Mizuho Securities
$170$184
Buy
8.31%
Upside
Reiterated
05/20/25
Tenet Healthcare (THC) PT Raised to $184 at MizuhoMizuho analyst Ann Hynes raised the price target on Tenet Healthcare (NYSE: THC) to $184.00 (from $170.00) while maintaining a Outperform rating.
Bank of America Securities Analyst forecast on THC
Joanna GajukBank of America Securities
Bank of America Securities
$165$180
Buy
5.95%
Upside
Reiterated
05/16/25
Tenet Healthcare (THC) PT Raised to $180 at BofA Securities following fireside chatBofA Securities analyst Joanna Gajuk raised the price target on Tenet Healthcare (NYSE: THC) to $180.00 (from $165.00) while maintaining a Buy rating.
J.P. Morgan Analyst forecast on THC
Benjamin RossiJ.P. Morgan
J.P. Morgan
$190
Buy
11.84%
Upside
Reiterated
05/14/25
Analysts Are Bullish on Top Healthcare Stocks: Codexis (CDXS), Neurocrine (NBIX)
Truist Financial Analyst forecast on THC
David S MacdonaldTruist Financial
Truist Financial
$175$190
Buy
11.84%
Upside
Reiterated
05/12/25
Tenet Healthcare price target raised to $190 from $175 at TruistTenet Healthcare price target raised to $190 from $175 at Truist
Goldman Sachs Analyst forecast on THC
Jamie PerseGoldman Sachs
Goldman Sachs
$134$154
Hold
-9.35%
Downside
Reiterated
05/05/25
Tenet Healthcare (THC) PT Raised to $154 at Goldman SachsGoldman Sachs analyst Jamie Perse raised the price target on Tenet Healthcare (NYSE: THC) to $154.00 (from $134.00) while maintaining a Neutral rating.
UBS
$217$230
Buy
35.38%
Upside
Reiterated
04/30/25
Tenet Healthcare price target raised to $230 from $217 at UBSTenet Healthcare price target raised to $230 from $217 at UBS
RBC Capital Analyst forecast on THC
Ben HendrixRBC Capital
RBC Capital
$183$189
Buy
11.25%
Upside
Reiterated
04/30/25
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (NASDAQ: ABVX), Atricure (NASDAQ: ATRC) and Tenet Healthcare (NYSE: THC)
KeyBanc
$185
Buy
8.89%
Upside
Reiterated
04/30/25
KeyBanc Remains a Buy on Tenet Healthcare (THC)
Guggenheim Analyst forecast on THC
Jason CassorlaGuggenheim
Guggenheim
$165$180
Buy
5.95%
Upside
Reiterated
04/29/25
Tenet Healthcare price target raised to $180 from $165 at GuggenheimTenet Healthcare price target raised to $180 from $165 at Guggenheim
TD Cowen
$175
Buy
3.01%
Upside
Reiterated
04/29/25
Tenet Healthcare's Strong Performance and Strategic Focus Justify Buy Rating
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Tenet Healthcare

1 Month
xxx
Success Rate
17/21 ratings generated profit
81%
Average Return
+8.99%
reiterated a xxx
rating 25 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 80.95% of your transactions generating a profit, with an average return of +8.99% per trade.
3 Months
xxx
Success Rate
25/35 ratings generated profit
71%
Average Return
+10.32%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of +10.32% per trade.
1 Year
David S MacdonaldTruist Financial
Success Rate
19/21 ratings generated profit
90%
Average Return
+33.61%
reiterated a buy rating 25 days ago
Copying David S Macdonald's trades and holding each position for 1 Year would result in 90.48% of your transactions generating a profit, with an average return of +33.61% per trade.
2 Years
xxx
Success Rate
21/21 ratings generated profit
100%
Average Return
+78.80%
reiterated a xxx
rating 25 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +78.80% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

THC Analyst Recommendation Trends

Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
0
0
1
1
1
Buy
18
17
29
23
23
Hold
2
1
2
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
20
18
32
26
26
In the current month, THC has received 24 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. THC average Analyst price target in the past 3 months is 184.71.
Each month's total comprises the sum of three months' worth of ratings.

THC Financial Forecast

THC Earnings Forecast

Next quarter’s earnings estimate for THC is $2.87 with a range of $2.51 to $3.15. The previous quarter’s EPS was $4.36. THC beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year THC has Outperformed its overall industry.
Next quarter’s earnings estimate for THC is $2.87 with a range of $2.51 to $3.15. The previous quarter’s EPS was $4.36. THC beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year THC has Outperformed its overall industry.

THC Sales Forecast

Next quarter’s sales forecast for THC is $5.16B with a range of $5.09B to $5.22B. The previous quarter’s sales results were $5.22B. THC beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.51% of the time in the same period. In the last calendar year THC has Outperformed its overall industry.
Next quarter’s sales forecast for THC is $5.16B with a range of $5.09B to $5.22B. The previous quarter’s sales results were $5.22B. THC beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.51% of the time in the same period. In the last calendar year THC has Outperformed its overall industry.

THC Stock Forecast FAQ

What is THC’s average 12-month price target, according to analysts?
Based on analyst ratings, Tenet Healthcare Corp.’s 12-month average price target is 184.71.
    What is THC’s upside potential, based on the analysts’ average price target?
    Tenet Healthcare Corp. has 8.72% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is THC a Buy, Sell or Hold?
          Tenet Healthcare Corp. has a consensus rating of Strong Buy which is based on 15 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Tenet Healthcare Corp.’s price target?
            The average price target for Tenet Healthcare Corp. is 184.71. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $230.00 ,the lowest forecast is $137.00. The average price target represents 8.72% Increase from the current price of $169.89.
              What do analysts say about Tenet Healthcare Corp.?
              Tenet Healthcare Corp.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Streets Analysts.
                How can I buy shares of THC?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis